Neutrophils: The Double-Edged Immune Cells Shaping Oncolytic Virus Therapy
A new review reveals how neutrophils can either enhance or undermine oncolytic virus therapy through N1/N2 polarization, virus delivery, and ...
A new review reveals how neutrophils can either enhance or undermine oncolytic virus therapy through N1/N2 polarization, virus delivery, and ...
Researchers have developed a yeast-based genome shuffling platform that generates infectious chimeric poxviruses from multiple parental species, yielding clones with ...
Researchers argue that the innate immune sensor ZBP1, which detects left-handed Z-form nucleic acids and triggers necroptosis, can be pharmacologically ...
A new review in Molecular Biology Reports maps how checkpoint inhibitors, engineered cell therapies, and emerging immunotherapies are transforming treatment ...
A five-year, $13.1 million NIH grant will fund engineered, nontoxic Salmonella designed to deliver radiopharmaceutical therapy, viral payloads, and immune-targeting ...
A new review proposes co-designing oncolytic viruses and CAR-T or CAR-NK cells as a modular, self-amplifying therapeutic system to overcome ...
A new review charts how mRNA, peptide, cell, and virus-based therapeutic vaccines, supercharged by AI-driven neoantigen prediction and combination immunotherapy, ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A new BMC Medicine review distills design rules from early clinical studies of engineered bacteria, arguing that synthetic biology can ...
A new review details how tumor-infiltrating lymphocyte, CAR-T, and TCR-engineered cell therapies are transforming melanoma treatment and the engineering breakthroughs ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine